Associations Between Genetic Polymorphisms of Epidermal Growth Factor Receptor (EGFR) and Survival of Colorectal Cancer (CRC) Patients Treated with 5-Fluorouracil-Based Chemotherapy

Author： Lai Ching-Yu   Sung Fung-Chang   Hsieh Ling-Ling   Tang Reiping   Chiou Hung-Yi   Wu Fang-Yang   Yeh Chih-Ching  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.3, 2013-12, pp. : 599-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

By Giaccone Giuseppe   Iacona Renee   Fandi Abderrahim   Janas Mette   Ochs Judith   Herbst Roy   Johnson David  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 467-476

Springer Publishing Company

Access to resources Recommend Favorite

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

By Tas Faruk   Karabulut Senem   Serilmez Murat   Ciftci Rumeysa   Duranyildiz Derya  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 631-637

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy

By Huang Zhao-Hui   Hua Dong   Li Li-Hua   Zhu Jing-De  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1129-1134

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

By Sartore-Bianchi Andrea  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 19-28

Springer Publishing Company

Access to resources Recommend Favorite